Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Agonistic antibodies specifically binding CD40 and methods of use

Agonistic antibodies specifically binding CD40 and methods of use

US Patent 10544229 · Granted Jan 28, 2020

Estimated economic value: $87,714,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

FLT3 agonist antibodies and uses thereof2025
Mounting systems, kits, and methods that provide access to a secondary device on2025
Anti-idiotypic antibodies against anti-KLK2 antibodies2024
Antibodies binding to vista at acidic pH2024
Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D an2024
Anti-CD30L antibodies and uses thereof2024
Materials and methods for improved single chain variable fragments2023
PSMA binding agents and uses thereof2023
Neutralizing human anti-CD27 antibodies2023
Neutralizing human anti-CD27 antibodies2023
Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D an2023
Immunostimulatory agonistic antibodies for use in treating cancer2023